Relationship between miR-143/145 cluster variations and cancer risk: proof from a Meta-analysis

References

• West, A. K.; Wullkopf, L.; Christensen, A.; et al. Dynamics of Cancerous Tissue Correlates with Invasiveness. Sci. Rep. 2017, 7, 43800.
   PubMed Web of Science ®Google Scholar
• Mortality and Causes of Death. Global, Regional, and National Life Expectancy, All-Cause Mortality, and Cause-Specific Mortality for 249 Causes of Death, 1980–2015: A Systematic Analysis for the Global Burden of Disease Study 2015. Lancet (London, England). 2016, 388, 1459–1544.
   PubMed Web of Science ®Google Scholar
• Hanly, P.; Soerjomataram, I.; Sharp, L. Measuring the Societal Burden of Cancer: The Cost of Lost Productivity Due to Premature Cancer-Related Mortality in Europe. Int. J. Cancer. 2015, 136, E136–E145.
   PubMed Web of Science ®Google Scholar
• Guan, H.; Li, C.; Gao, X.-H.; et al. Association of CD14 Gene‐260 C > T and‐561 C > T Polymorphisms with Cancer Susceptibility: A Meta‐Analysis. J. Gene Med. 2019, e3151.
   Web of Science ®Google Scholar
• Parsa, N. Environmental Factors Inducing Human Cancers. Iran. J. Public Health. 2012, 41, 1–9.
   PubMed Web of Science ®Google Scholar
• Vogelstein, K. Cancer Genes and the Pathways They Control. Nat. Med. 2004, 10, 789–799.
   PubMed Web of Science ®Google Scholar
• Deng, Z.; Fan, Y. Single Nucleotide Polymorphisms and Cancer Susceptibility. Oncotarget. 2017, 8, 110635–110649.
   PubMedGoogle Scholar
• Zhao, W. Quantitative Assessment of Pre-miR-218 rs11134527 Polymorphism and Cancer Risk in Chinese Population. OncoTargets Ther. 2015, 8, 1859.
   PubMed Web of Science ®Google Scholar
• Gregory, L. MicroRNA Biogenesis Pathways in Cancer. Nat. Rev. Cancer. 2015, 15, 321–333.
   PubMed Web of Science ®Google Scholar
• Almeida, M. I.; Reis, R. M.; Calin, G. A. MicroRNA History: Discovery, Recent Applications, and Next Frontiers. Mutat. Res. 2011, 717, 1–8.
   PubMed Web of Science ®Google Scholar
• Cowland, J. B.; Hother, C.; Grønbaek, K. MicroRNAs and Cancer. APMIS 2007, 115, 1090–1106.
   PubMed Web of Science ®Google Scholar
• Sheervalilou, S.; Hasanifard, S.; Mehranfar, L.; et al. Electrochemical Nano-Biosensors as Novel Approach for the Detection of Lung Cancer-Related MicroRNAs. Curr. Mol. Med. 2020, 20, 13–35.
   Web of Science ®Google Scholar
• Voorhoeve, P. M.; le Sage, C.; Schrier, M.; et al. A Genetic Screen Implicates miRNA-372 and miRNA-373 as Oncogenes in Testicular Germ Cell Tumors. Cell. 2006, 124, 1169–1181.
   PubMed Web of Science ®Google Scholar
• Almeida, C. The miR-143/miR-145 Cluster and the Tumor Microenvironment: Unexpected Roles. Genome Med. 2016, 8, 29–29.
   PubMed Web of Science ®Google Scholar
• Li, L.; Pan, X.; Li, Z.; et al. Association between Polymorphisms in the Promoter Region of miR-143/145 and Risk of Colorectal Cancer. Human Immunology 2013, 74, 993–997.
   PubMed Web of Science ®Google Scholar
• Mihaylova, G. M.; Ivanova, D.; Manev, R.; et al. 109P - Association of rs363293 Single Nucleotide Polymorphism in Promoter Region of miRNA-143/145 with Susceptibility to Colorectal Cancer and with Patients' Outcome. Annals of Oncology 2019, 30.
   Web of Science ®Google Scholar
• Wu, J.; Huang, Q.; Meng, H. D.; et al. A Functional rs353293 Polymorphism in the Promoter of miR-143/145 Is Associated with a Reduced Risk of Bladder Cancer. PloS One. 2016, 11, e0159115.
   PubMed Web of Science ®Google Scholar
• Liang, Y.; Sun, R.; Li, L.; et al. A Functional Polymorphism in the Promoter of MiR-143/145 is Associated with the Risk of Cervical Squamous Cell Carcinoma in Chinese Women: A Case-Control Study. Medicine (Baltimore). 2015, 94, e1289.
   PubMed Web of Science ®Google Scholar
• Bradshaw, G.; Haupt, L. M.; Aquino, E. M.; et al. Single Nucleotide Polymorphisms in MIR143 Contribute to Protection against Non-Hodgkin Lymphoma (NHL) in Caucasian Populations. Genes. 2019, 10.
   PubMed Web of Science ®Google Scholar
• Liang, Y.; Sun, R.; Li, L.; et al. A Functional Polymorphism in the Promoter of MiR-143/145 is Associated with the Risk of Cervical Squamous Cell Carcinoma in Chinese Women: A Case–Control Study. Medicine (Baltimore). 2015, 94.
   Web of Science ®Google Scholar
• Yuan, F.; Sun, R.; Li, L.; et al. A Functional Variant rs353292 in the Flanking Region of miR-143/145 Contributes to the Risk of Colorectal Cancer. Sci. Rep. 2016, 6.
   Web of Science ®Google Scholar
• Martorell-Marugan, T.-D.; Alarcon-Riquelme, C.-S. MetaGenyo: A Web Tool for Meta-Analysis of Genetic Association Studies. BMC Bioinf. 2017, 18.
   PubMed Web of Science ®Google Scholar
• Higgins, T. Quantifying Heterogeneity in a Meta‐Analysis. Stat. Med. 2002, 21, 1539–1558.
   PubMed Web of Science ®Google Scholar
• DerSimonian, L. Meta-Analysis in Clinical Trials. Control. Clin. Trials. 1986, 7, 177–188.
   PubMed Web of Science ®Google Scholar
• Mantel, H. Statistical Aspects of the Analysis of Data from Retrospective Studies of Disease. J. Natl. Cancer Inst. 1959, 22, 719–748.
   PubMed Web of Science ®Google Scholar
• Egger, S.; Schneider, M. Bias in Meta-Analysis Detected by a Simple, Graphical Test. BMJ. 1997, 315, 629–634.
   PubMed Web of Science ®Google Scholar
• Li, C.; Zhang, Y.; Li, Y.; et al. The Association of Polymorphisms in miRNAs with Nonsmall Cell Lung Cancer in a Han Chinese Population. Cancer Manag. Res. 2018, 10.
   Web of Science ®Google Scholar
• Kotarac, N.; Dobrijevic, Z.; Matijasevic, S.; et al. Analysis of Association of Potentially Functional Genetic Variants within Genes Encoding miR-34b/c, miR-378 and miR-143/145 with Prostate Cancer in Serbian Population. EXCLI J. 2019, 18, 515.
   PubMed Web of Science ®Google Scholar
• Chu, H.; Zhong, D.; Tang, J.; et al. A Functional Variant in miR-143 Promoter Contributes to Prostate Cancer Risk. Arch. Toxicol. 2016, 90, 403–414.
   PubMed Web of Science ®Google Scholar
• Sun, R.; Chen, P.; Li, L.; et al. A Polymorphism rs4705341 in the Flanking Region of miR-143/145 Predicts Risk and Prognosis of Colorectal Cancer. Oncotarget. 2016, 7, 62084.
   PubMedGoogle Scholar
• Yang, L.; Quan, L.; Hao.; et al. Association between Two Polymorphisms in the Promoter Region of miR-143/miR-145 and the Susceptibility of Lung Cancer in Northeast Chinese Nonsmoking Females. DNA Cell Biol. 2019, 38, 814–823.
   PubMed Web of Science ®Google Scholar
• Yuan, F.; Sun, R.; Li, L.; et al. A Functional Variant rs353292 in the Flanking Region of miR-143/145 Contributes to the Risk of Colorectal Cancer. Sci. Rep. 2016, 6, 30195.
   PubMed Web of Science ®Google Scholar
• Ying, H. Q.; Peng, H. X.; He, B. S.; et al. MiR-608, Pre-miR-124-1 and Pre-miR26a-1 Polymorphisms Modify Susceptibility and Recurrence-Free Survival in Surgically Resected CRC Individuals. Oncotarget. 2016, 7, 75865.
   PubMedGoogle Scholar
• Xie, K.; Wang, C.; Qin, N.; et al. Genetic Variants in Regulatory Regions of microRNAs Are Associated with Lung Cancer Risk. Oncotarget. 2016, 7, 47966.
   PubMedGoogle Scholar
• Liu, J.; Mao, Y.; Zhang, D.; et al. RETRACTED: MiR-143 Inhibits Tumor Cell Proliferation and Invasion by Targeting STAT3 in Esophageal Squamous Cell Carcinoma. Cancer Lett. 2016, 373.
   Web of Science ®Google Scholar
• Wang, Q.; Cai, J.; Wang, J. MiR-143 Inhibits EGFR-Signaling-Dependent Osteosarcoma Invasion. Tumor Biol. 2014, 35, 12743–12748.
   PubMedGoogle Scholar
• Zhang, W.; Wang, Q.; Yu, M.; et al. MicroRNA-145 Function as a Cell Growth Repressor by Directly Targeting c-Myc in Human Ovarian Cancer. Technol. Cancer Res. Treat. 2014, 13, 161–168.
   PubMed Web of Science ®Google Scholar
• Chen, J. J.; Cai, W. Y.; Liu, X. W.; et al. Reverse Correlation between MicroRNA-145 and FSCN1 Affecting Gastric Cancer Migration and Invasion. PLoS One. 2015, 10, e0126890.
   PubMed Web of Science ®Google Scholar
• Qin, J.; Wang, F.; Jiang, H.; et al. MicroRNA-145 Suppresses Cell Migration and Invasion by Targeting Paxillin in Human Colorectal Cancer Cells. Int. J. Clin. Exp. Path. 2015, 8, 1328.
   PubMed Web of Science ®Google Scholar
• Larne, O.; Hagman, Z.; Lilja, H.; et al. miR-145 Suppress the Androgen Receptor in Prostate Cancer Cells and Correlates to Prostate Cancer Prognosis. Carcinogenesis. 2015, 36, 858–866.
   PubMed Web of Science ®Google Scholar
• Ye, D.; Shen, Z.; Zhou, S. Function of microRNA-145 and Mechanisms Underlying Its Role in Malignant Tumor Diagnosis and Treatment. Cancer Manag. Res. 2019, 11, 969–979.
   PubMed Web of Science ®Google Scholar
• Lin, T.; Dong, W.; Huang, J.; et al. MicroRNA-143 as a Tumor Suppressor for Bladder Cancer. J. Urol. 2009, 181, 1372–1380.
   PubMed Web of Science ®Google Scholar
• Liu, L.; Yu, X.; Guo, X.; et al. miR-143 is Downregulated in Cervical Cancer and Promotes Apoptosis and Inhibits Tumor Formation by Targeting Bcl-2. Mol. Med. Rep. 2012, 5, 753–760.
   PubMed Web of Science ®Google Scholar
• Sima, X.; Sun, H.; Zhou, P. Association between Functional Polymorphisms in the Promoter of the miR-143/145 Cluster and Risk of Intracranial Aneurysm. Sci. Rep. 2017, 7, 43633–43633.
   PubMed Web of Science ®Google Scholar